Literature DB >> 5471772

Disturbance of calcium metabolism by anticonvulsant drugs.

A Richens, D J Rowe.   

Abstract

A survey of calcium metabolism in epileptic patients in a residential centre showed a subnormal serum calcium level in 22.5% of patients and a raised alkaline phosphatase in 29%. Hypocalcaemia was related to high dosage of anticonvulsant drugs, to multiple drug therapy, and to the use of individual anticonvulsant drugs in the following order, with decreasing order of importance: pheneturide, primidone, phenytoin, phenobarbitone. Subnormal serum calcium levels occurred more commonly in patients with a raised liver alkaline phosphatase isoenzyme than in those whose phosphatase was mainly of bone origin.Preliminary results of treatment with calciferol suggested that the disturbance of calcium metabolism was the result of vitamin D deficiency. It is possible that anticonvulsant drugs accelerate the breakdown of vitamin D by liver enzyme induction.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5471772      PMCID: PMC1819609          DOI: 10.1136/bmj.4.5727.73

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  TRINURIDE IN THE TREATMENT OF MAJOR EPILEPSY.

Authors:  J A WRIGHT
Journal:  Epilepsia       Date:  1965-03       Impact factor: 5.864

2.  Calcium metabolism in epilepsy.

Authors:  M N Rudra; S De; M S Rudra
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

3.  Treatment of intractable temporal lobe epilepsy with pheneturide.

Authors:  C J Vas; M J Parsonage
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

4.  Osteomalacia with long-term anticonvulsant therapy in epilepsy.

Authors:  C E Dent; A Richens; D J Rowe; T C Stamp
Journal:  Br Med J       Date:  1970-10-10

5.  Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine.

Authors:  L V Avioli; S W Lee; J E McDonald; J Lund; H F DeLuca
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

  5 in total
  79 in total

1.  Bone morphology in epileptics.

Authors:  O Johnell; B E Nilsson; A Wallöe; P E Wiklund
Journal:  Calcif Tissue Int       Date:  1979-10-31       Impact factor: 4.333

2.  Bone mineral content in epileptics.

Authors:  L Lidgren; B E Nilsson; A Wallöe
Journal:  Calcif Tissue Int       Date:  1979-10-31       Impact factor: 4.333

3.  Effects of anticonvulsants and inactivity on bone disease in epileptics.

Authors:  L E Murchison; P D Bewsher; M Chesters; J Gilbert; G Catto; E Law; E McKay; H S Ross
Journal:  Postgrad Med J       Date:  1975-01       Impact factor: 2.401

4.  The Association Between Antiepileptic Drugs and Bone Disease.

Authors:  Alison M. Pack
Journal:  Epilepsy Curr       Date:  2003-05       Impact factor: 7.500

5.  The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Authors:  A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

6.  Steady-state plasma nortriptyline concentrations in epileptic patients.

Authors:  R A Braithwaite; R J Flanagan; A Richens
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

7.  Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.

Authors:  C Christiansen; P Rodbro; O Munck
Journal:  Br Med J       Date:  1975-05-17

Review 8.  Drug-induced arthritis and arthralgia.

Authors:  F D Hart
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

9.  Hypocalcaemic cardiac failure.

Authors:  D P Brenton; J Gonzales; A B Pollard
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

10.  [The frequency of adult anticonvulsant osteomalacia in relation to duration of therapy and dosage of anticonvulsants (author's transl)].

Authors:  U Mehregan; K H Krause; P Prager
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.